References
- Apostolopoulos, Y., & Sonmez, S. F. (2007). Social networks, social capital, and HIV risks among migrants. In Population mobility and infectious disease (pp. 55–72). New York, NY: Springer.
- Armenta, R., Roth, A., Wagner, K., Strathdee, S. A., Brodine, S. K., Cuevas-Mota, J., … Garfein, R. S. (2015). Prevalence and correlates of the use of prefilled syringes among persons who inject drugs in San Diego, CA. Journal of Urban Health, 92(6), 1–11.
- Betanzos, S. (September 6, 2014). Incautaron 750 mil dólares, en heroína. El Mexicano. Estatal.
- Bluthenthal, R. N., Kral, A. H., Erringer, E. A., & Edlin, B. R. (1999). Drug paraphernalia laws and injection-related infectious disease risk among drug injectors. Journal of Drug Issues, 29(1), 1–16.
- Bluthenthal, R. N., Lorvick, J., Kral, A. H., Erringer, E. A., & Kahn, J. G. (1999). Collateral damage in the War on drugs: HIV risk behaviors among injection drug users. International Journal of Drug Policy, 10, 25–38.
- Bourgois, P. (1998). The moral economies of homeless heroin addicts: Confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Substance Use & Misuse, 33(11), 2323–2351.
- Brouwer, K. C., Case, P., Ramos, R., Magis-Rodrigruez, C., Bucardo, J., Patterson, T. L., & Strathdee, S. A. (2006). Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico. Substance Use & Misuse, 41(5), 707–727.
- Ciccarone, D. (2009). Heroin in brown, black and white: Structural factors and medical consequences in the US heroin market. International Journal of Drug Policy, 20(3), 277–282.
- Ciccarone, D., & Bourgois, P. (2003). Explaining the geographical variation of HIV among injection drug users in the United States. Substance Use & Misuse, 38(14), 2049–2063.
- Clatts, M. C., Heimer, R., Abdala, N., Goldsamt, L. A., Sotheran, J. L., Anderson, K. T., … Kyriakides, T. (1999). HIV-1 Transmission in injection Paraphernalia: Heating drug solutions may inactivate HIV-1. Journal of Acquired Immune Deficiency Syndromes, 22(2), 194–199.
- Costenbader, E. C., Astone, N. M., & Latkin, C. A. (2006). The dynamics of injection drug users' personal networks and HIV risk behaviors. Addiction, 101(7), 1003–1013.
- Granovetter, M. (1983). The strength of weak ties: A network theory revisited. Sociological Theory, 1(1), 201–233.
- Heimer, R., & Abdala, N. V. (2000). Viability of HIV-1 in syringes: Implications for interventions among injection drug users. AIDS Reader, 10(7), 410–417.
- Hoffmann, J. P., Su, S. S., & Pach, A. (1997). Changes in network characteristics and HIV risk behavior among injection drug users. Drug & Alcohol Dependence, 46(1–2), 41–51.
- Mickey, R. M., & Greenland, S. (1989). The impact of confounder slection criteria on effect estimation. American Journal of Epidemiology, 129(1), 125–137.
- Morris, M., Podhisita, C., Wawer, M. J., & Handcock, M. S. (1996). Bridge populations in the spread of HIV/AIDS in Thailand. AIDS, 10(11), 1265–1271.
- Rachlis, B., Brouwer, K. C., Mills, E. J., Hayes, M., Kerr, T., & Hogg, R. S. (2007). Migration and transmission of blood-borne infections among injection drug users: Understanding the epidemiologic bridge. Drug & Alcohol Dependence, 90(2–3), 107–119.
- Rao, R. B., & Hoffman, R. S. (1997). Medical complications of substance abuse. Advanced Emergency Nursing Journal, 19(4), 81–88.
- Rhodes, T. (2002). The ‘risk environment’: A framework for understanding and reducing drug-related harm. International Journal of Drug Policy, 13(2), 85–94. doi: https://doi.org/10.1016/S0955-3959(02)00007-5
- Rothenberg, R. B., Potterat, J. J., Woodhouse, D. E., Muth, S. Q., Darrow, W. W., & Klovdahl, A. S. (1998). Social network dynamics and HIV transmission. AIDS, 12(12), 1529–1536.
- Strathdee, S. A., & Beyrer, C. (2015). Threading the needle—How to stop the HIV outbreak in Rural Indiana. New England Journal of Medicine, 373(5), 397–399.
- U. S. Department of Justice. Drug Enforcement Agency Administration [DEA]. (2013). 2011 Heroin Domestic Monitor Program. (Report No. DEA-NWW-RPT-005-13).